| Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic A Sud, ME Jones, J Broggio, C Loveday, B Torr, A Garrett, DL Nicol, ... Annals of Oncology 31 (8), 1065-1074, 2020 | 595 | 2020 |
| Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study A Sud, B Torr, ME Jones, J Broggio, S Scott, C Loveday, A Garrett, ... The Lancet Oncology 21 (8), 1035-1044, 2020 | 501 | 2020 |
| Genome-wide association studies of cancer: current insights and future perspectives A Sud, B Kinnersley, RS Houlston Nature Reviews Cancer 17 (11), 692-704, 2017 | 389 | 2017 |
| Association analyses identify 31 new risk loci for colorectal cancer susceptibility PJ Law, M Timofeeva, C Fernandez-Rozadilla, P Broderick, J Studd, ... Nature communications 10 (1), 2154, 2019 | 217 | 2019 |
| Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma S Bird, A Panopoulou, RL Shea, M Tsui, R Saso, A Sud, S West, K Smith, ... The Lancet Haematology 8 (6), e389-e392, 2021 | 143 | 2021 |
| Cancer genetics, precision prevention and a call to action C Turnbull, A Sud, RS Houlston Nature genetics 50 (9), 1212-1218, 2018 | 134 | 2018 |
| Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma M Went, A Sud, A Försti, BM Halvarsson, N Weinhold, S Kimber, ... Nature communications 9 (1), 3707, 2018 | 122 | 2018 |
| The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1 D Hanson, PG Murray, A Sud, SA Temtamy, M Aglan, A Superti-Furga, ... The American Journal of Human Genetics 84 (6), 801-806, 2009 | 109 | 2009 |
| Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis S May-Wilson, A Sud, PJ Law, K Palin, S Tuupanen, A Gylfe, ... European Journal of Cancer 84, 228-238, 2017 | 107 | 2017 |
| Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study C Loveday, A Sud, ME Jones, J Broggio, S Scott, F Gronthound, B Torr, ... Gut 70 (6), 1053-1060, 2021 | 95* | 2021 |
| Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer H Rodriguez‐Broadbent, PJ Law, A Sud, K Palin, S Tuupanen, A Gylfe, ... International journal of cancer 140 (12), 2701-2708, 2017 | 88 | 2017 |
| Risk of second cancer in Hodgkin lymphoma survivors and influence of family history A Sud, H Thomsen, K Sundquist, RS Houlston, K Hemminki Journal of Clinical Oncology 35 (14), 1584-1590, 2017 | 83 | 2017 |
| Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk A Sud, S Chattopadhyay, H Thomsen, K Sundquist, J Sundquist, ... Blood, The Journal of the American Society of Hematology 134 (12), 960-969, 2019 | 78 | 2019 |
| Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling D Hanson, PG Murray, T Coulson, A Sud, A Omokanye, E Stratta, ... Journal of molecular endocrinology 49 (3), 267, 2012 | 72 | 2012 |
| Will polygenic risk scores for cancer ever be clinically useful? A Sud, C Turnbull, R Houlston Npj Precision Oncology 5 (1), 40, 2021 | 56 | 2021 |
| Impact of atopy on risk of glioma: a Mendelian randomisation study L Disney-Hogg, AJ Cornish, A Sud, PJ Law, B Kinnersley, DI Jacobs, ... BMC medicine 16, 1-13, 2018 | 54 | 2018 |
| Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility A Sud, H Thomsen, PJ Law, A Försti, MI da Silva Filho, A Holroyd, ... Nature communications 8 (1), 1892, 2017 | 52 | 2017 |
| Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia G Zheng, S Chattopadhyay, A Sud, K Sundquist, J Sundquist, A Försti, ... British Journal of Haematology, 2019 | 47 | 2019 |
| Epidemiology, genetics and treatment of multiple myeloma and precursor diseases K Hemminki, A Försti, R Houlston, A Sud International Journal of Cancer, 2021 | 44 | 2021 |
| Realistic expectations are key to realising the benefits of polygenic scores A Sud, RH Horton, AD Hingorani, I Tzoulaki, C Turnbull, RS Houlston, ... Bmj 380, 2023 | 42 | 2023 |
Clare TurnbullProfessor of Translational Cancer Genetics, Institute of Cancer Research在 icr.ac.uk 的电子邮件经过验证
